Poziotinib
-
Catalog number9519-50
-
PricePlease ask
-
Size50 mg
-
-
Alternative_name1-(4-((4-((3,4-dichloro-2-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)piperidin-1-yl)prop-2-en-1-one; HM781-36B; NOV120101
-
DescriptionPoziotinib is an irreversible Pan-HER inhibitor with IC₅₀s of 3 nM, 5 nM and 23 nM for HER1, HER2, and HER4 respectively. Displays antineoplastic activity.
-
CAS Number1092364-38-9
-
Structure AvailableYes
-
Salt FormNo
-
Molecular FormulaC₂₃H₂₁Cl₂FN₄O₃
-
Molecular Weight491.34
-
Cell PermeableYes
-
Purity≥98% by HPLC
-
SolubilitiesDMSO (>5 mg/ml)
-
HandlingProtect from air and light
-
Tag LineA an irreversible Pan-HER inhibitor
-
Storage Condition-20°C
-
Shipping Conditiongel pack
-
Shelf Life36 months
-
PubChem CID25127713
-
SMILESCOC1=C(C=C2C(=C1)N=CN=C2NC3=C(C(=C(C=C3)Cl)Cl)F)OC4CCN(CC4)C(=O)C=C
-
InChiInChI=1S/C23H21Cl2FN4O3/c1-3-20(31)30-8-6-13(7-9-30)33-19-10-14-17(11-18(19)32-2)27-12-28-23(14)29-16-5-4-15(24)21(25)22(16)26/h3-5,10-13H,1,6-9H2,2H3,(H,27,28,29)
-
InChi KeyLPFWVDIFUFFKJU-UHFFFAOYSA-N
-
MSDS AvailableYes
-
Gene target
-
Short namePoziotinib
-
Alternative namePoziotinib
-